Triumpharma Inc. is a pioneer in developing systems and solutions for advanced drug delivery. We strive to bridge the gap between life science and modern healthcare.

Triumpharma Inc. develops technologies that enhance the performance of many of today's commonly available pharmaceutical products and new chemical entities that give raise to challenging bioavailability problems.

Triumpharma has strong technical capabilities to take products from feasibility to pilot scale. Triumpharma conducts formulation optimization studies, pre-clinical trials on animals, human clinical studies including bioavailability/ bioequivalence trial complying with the international guidelines. The company's core advantages are its extremely low-cost base, experienced staff with multi national experience, holding PhDs from western universities, high-quality research, a large pool of patient’s and volunteers, and fast formulation development meeting the necessary regulatory requirements.

We provide regulatory services (for clinical trials, PK/PD/BA/BE studies, and for preparing regulatory dossiers) to various major pharmaceutical companies & clients.

Our regulatory affairs and JFDA liaison staff is dedicated, well trained, and familiar with JFDA regulations and Laws, as well as international and ICH requirements.

Our clear and good understanding of Jordanian and international regulatory requirements and anticipations of questions that regulatory authorities may ask swift and speed up approvals.

Services offered at Triumpharma include

  • Liaisoning on behalf of clients,
  • Making regulatory submissions
  • Providing guidance on Jordanian regulatory environment & requirements,
  • Compiling dossiers, and
  • Receiving registration documents on behalf of client

 

This publication has been produced with the assistance of the European Union in cooperation with Jordan Enterprise Development Corporation. *

* The contents of this publication are the sole responsibility of Triumpharma and can in no way betaken to reflect the views of the European Union & Jordan Enterprise Development Corporation